Evaluating the Effectiveness of a Novel Skin Barrier Protectant in a Patient with Acute Radiodermatitis of the Vulva: A Case Report
| Autor: | Stefan Claes, Sandrine Censabella, Leen Van Bever, Paul Bulens, Jolien Robijns, Luc Pannekoeke, Evelyn Van de Werf |
|---|---|
| Přispěvatelé: | Van Bever, Leen, Claes, Stefan, ROBIJNS, Jolien, Censabella, Sandrine, Pannekoeke, Luc, Van de Werf, Evelyn, BULENS, Paul |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Skin barrier medicine.medical_treatment Dermatology Vulva law.invention 030207 dermatology & venereal diseases 03 medical and health sciences Nursing care 0302 clinical medicine Belgium Randomized controlled trial law medicine case report Humans radiotherapy Aged Aged 80 and over Advanced and Specialized Nursing Vulvar Neoplasms integumentary system business.industry skin barrier protectant toxicity Cancer Architectural Accessibility 030208 emergency & critical care medicine Vulvar cancer radiation dermatitis Skin Care medicine.disease vulvar carcinoma Surgery Radiation therapy medicine.anatomical_structure Female Vulvar Carcinoma Radiodermatitis business |
| Zdroj: | Advances in Skin & Wound Care. 34:49-55 |
| ISSN: | 1538-8654 1527-7941 |
| DOI: | 10.1097/01.asw.0000722768.95461.82 |
| Popis: | Objective To evaluate the use of a novel skin barrier protectant in a patient treated with radiotherapy for vulvar cancer. Methods This case report was conducted in a radiotherapy department with two women undergoing radiotherapy for vulvar carcinoma. A novel skin barrier protectant was evaluated in one patient; the other underwent the institutional standard skin care protocol. Skin reactions and pain were evaluated using the Radiotherapy Oncology Group Criteria. Main results The patient who was treated with the skin protectant showed accelerated healing toward the end of radiotherapy, and this was accompanied with a decrease in pain (maximum pain score 6/10). In comparison, the patient treated with the standard skin care protocol had an extended healing process, experienced a higher pain level (maximum pain score 9/10), and required more nursing care. Conclusions This case report is the first to suggest that this novel skin barrier protectant could effectively manage acute radiodermatitis in patients with cancer. This case report hopes to lay the foundation for future randomized controlled trials with a larger and broader patient population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|